Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1997 Aug;50(8):640–644. doi: 10.1136/jcp.50.8.640

Expression of E-cadherin in oesophageal carcinomas from the UK and China: disparities in prognostic significance.

W G Jian 1, S J Darnton 1, K Jenner 1, L J Billingham 1, H R Matthews 1
PMCID: PMC500102  PMID: 9301546

Abstract

AIMS: To study the expression and prognostic significance of the cell adhesion molecule E-cadherin in oesophageal tumours from the UK (low risk area) and China (high risk area). METHODS: E-cadherin expression was measured immunohistochemically in resected tumours from 17 patients in the UK with adenocarcinoma, 23 patients from the UK with squamous carcinoma, and 30 patients from China with squamous carcinomas who survived for five years postoperatively and compared with similar tumours from patients in the same regions who did not survive (140 tumours in all). RESULTS: Normal squamous epithelial cells and well differentiated areas of tumours showed membranous staining for E-cadherin expression. Cytoplasmic staining, heterogeneous staining, or an absence of staining was seen in dysplastic epithelium and in less well differentiated areas of tumours. Only one of 140 primary tumours had homogeneous membranous expression. In tumours from UK patients with adenocarcinoma (p = 1.00) and from Chinese patients with squamous carcinomas (p = 0.06) there was no correlation between E-cadherin absence and non-survival. In tumours from UK patients with squamous carcinomas there was a significant correlation between absence of E-cadherin and non-survival (p = 0.009). Tumours from UK patients with squamous carcinoma who survived were significantly less likely to be E-cadherin absent than those from Chinese patients with squamous carcinomas who survived (p = 0.007). Multivariate analysis (n = 37 UK, paired data) showed that absence of E-cadherin in the primary tumour was a weak independent prognostic factor for non-survival (30% significance level; p = 0.26; odds ratio = 3.56). In UK nodal metastases there was no correlation between E-cadherin expression and survival. CONCLUSIONS: Squamous carcinomas from UK patients differed from both adenocarcinomas from UK patients and carcinomas from Chinese patients with respect to E-cadherin expression and prognostic significance. In tumours from UK patients, E-cadherin absence in the primary carcinoma (a weak independent prognostic factor) but not metastases correlated with non-survival.

Full text

PDF
640

Images in this article

642Image
on p.642
642Image
on p.642
642Image
on p.642
642Image
on p.642
643Image
on p.643

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Behrens J. Cadherins as determinants of tissue morphology and suppressors of invasion. Acta Anat (Basel) 1994;149(3):165–169. doi: 10.1159/000147572. [DOI] [PubMed] [Google Scholar]
  2. Bongiorno P. F., al-Kasspooles M., Lee S. W., Rachwal W. J., Moore J. H., Whyte R. I., Orringer M. B., Beer D. G. E-cadherin expression in primary and metastatic thoracic neoplasms and in Barrett's oesophagus. Br J Cancer. 1995 Jan;71(1):166–172. doi: 10.1038/bjc.1995.34. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bringuier P. P., Umbas R., Schaafsma H. E., Karthaus H. F., Debruyne F. M., Schalken J. A. Decreased E-cadherin immunoreactivity correlates with poor survival in patients with bladder tumors. Cancer Res. 1993 Jul 15;53(14):3241–3245. [PubMed] [Google Scholar]
  4. Böhm M., Totzeck B., Birchmeier W., Wieland I. Differences of E-cadherin expression levels and patterns in primary and metastatic human lung cancer. Clin Exp Metastasis. 1994 Jan;12(1):55–62. doi: 10.1007/BF01784334. [DOI] [PubMed] [Google Scholar]
  5. Doki Y., Shiozaki H., Tahara H., Inoue M., Oka H., Iihara K., Kadowaki T., Takeichi M., Mori T. Correlation between E-cadherin expression and invasiveness in vitro in a human esophageal cancer cell line. Cancer Res. 1993 Jul 15;53(14):3421–3426. [PubMed] [Google Scholar]
  6. Gamallo C., Palacios J., Suarez A., Pizarro A., Navarro P., Quintanilla M., Cano A. Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma. Am J Pathol. 1993 Apr;142(4):987–993. [PMC free article] [PubMed] [Google Scholar]
  7. Jiang W. G., Puntis M. C., Hallett M. B. Molecular and cellular basis of cancer invasion and metastasis: implications for treatment. Br J Surg. 1994 Nov;81(11):1576–1590. doi: 10.1002/bjs.1800811107. [DOI] [PubMed] [Google Scholar]
  8. Kadowaki T., Shiozaki H., Inoue M., Tamura S., Oka H., Doki Y., Iihara K., Matsui S., Iwazawa T., Nagafuchi A. E-cadherin and alpha-catenin expression in human esophageal cancer. Cancer Res. 1994 Jan 1;54(1):291–296. [PubMed] [Google Scholar]
  9. Katagiri A., Watanabe R., Tomita Y. E-cadherin expression in renal cell cancer and its significance in metastasis and survival. Br J Cancer. 1995 Feb;71(2):376–379. doi: 10.1038/bjc.1995.76. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Mayer B., Johnson J. P., Leitl F., Jauch K. W., Heiss M. M., Schildberg F. W., Birchmeier W., Funke I. E-cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular dedifferentiation and glandular disintegration. Cancer Res. 1993 Apr 1;53(7):1690–1695. [PubMed] [Google Scholar]
  11. Nigam A. K., Savage F. J., Boulos P. B., Stamp G. W., Liu D., Pignatelli M. Loss of cell-cell and cell-matrix adhesion molecules in colorectal cancer. Br J Cancer. 1993 Sep;68(3):507–514. doi: 10.1038/bjc.1993.377. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Otto T., Rembrink K., Goepel M., Meyer-Schwickerath M., Rübben H. E-cadherin: a marker for differentiation and invasiveness in prostatic carcinoma. Urol Res. 1993;21(5):359–362. doi: 10.1007/BF00296837. [DOI] [PubMed] [Google Scholar]
  13. Pignatelli M., Ansari T. W., Gunter P., Liu D., Hirano S., Takeichi M., Klöppel G., Lemoine N. R. Loss of membranous E-cadherin expression in pancreatic cancer: correlation with lymph node metastasis, high grade, and advanced stage. J Pathol. 1994 Dec;174(4):243–248. doi: 10.1002/path.1711740403. [DOI] [PubMed] [Google Scholar]
  14. Pignatelli M. E-cadherin: a biological marker of tumour differentiation. J Pathol. 1993 Oct;171(2):81–82. doi: 10.1002/path.1711710204. [DOI] [PubMed] [Google Scholar]
  15. Rasbridge S. A., Gillett C. E., Sampson S. A., Walsh F. S., Millis R. R. Epithelial (E-) and placental (P-) cadherin cell adhesion molecule expression in breast carcinoma. J Pathol. 1993 Feb;169(2):245–250. doi: 10.1002/path.1711690211. [DOI] [PubMed] [Google Scholar]
  16. Sakuragi N., Nishiya M., Ikeda K., Ohkouch T., Furth E. E., Hareyama H., Satoh C., Fujimoto S. Decreased E-cadherin expression in endometrial carcinoma is associated with tumor dedifferentiation and deep myometrial invasion. Gynecol Oncol. 1994 May;53(2):183–189. doi: 10.1006/gyno.1994.1113. [DOI] [PubMed] [Google Scholar]
  17. Sarbia M., Porschen R., Borchard F., Horstmann O., Willers R., Gabbert H. E. p53 protein expression and prognosis in squamous cell carcinoma of the esophagus. Cancer. 1994 Oct 15;74(8):2218–2223. doi: 10.1002/1097-0142(19941015)74:8<2218::aid-cncr2820740803>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  18. Schipper J. H., Frixen U. H., Behrens J., Unger A., Jahnke K., Birchmeier W. E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis. Cancer Res. 1991 Dec 1;51(23 Pt 1):6328–6337. [PubMed] [Google Scholar]
  19. Shiozaki H., Oka H., Inoue M., Tamura S., Monden M. E-cadherin mediated adhesion system in cancer cells. Cancer. 1996 Apr 15;77(8 Suppl):1605–1613. doi: 10.1002/(SICI)1097-0142(19960415)77:8<1605::AID-CNCR28>3.0.CO;2-2. [DOI] [PubMed] [Google Scholar]
  20. Shiozaki H., Tahara H., Oka H., Miyata M., Kobayashi K., Tamura S., Iihara K., Doki Y., Hirano S., Takeichi M. Expression of immunoreactive E-cadherin adhesion molecules in human cancers. Am J Pathol. 1991 Jul;139(1):17–23. [PMC free article] [PubMed] [Google Scholar]
  21. Swami S., Kumble S., Triadafilopoulos G. E-cadherin expression in gastroesophageal reflux disease, Barrett's esophagus, and esophageal adenocarcinoma: an immunohistochemical and immunoblot study. Am J Gastroenterol. 1995 Oct;90(10):1808–1813. [PubMed] [Google Scholar]
  22. Takeichi M. The cadherins: cell-cell adhesion molecules controlling animal morphogenesis. Development. 1988 Apr;102(4):639–655. doi: 10.1242/dev.102.4.639. [DOI] [PubMed] [Google Scholar]
  23. Vessey C. J., Wilding J., Folarin N., Hirano S., Takeichi M., Soutter P., Stamp G. W., Pignatelli M. Altered expression and function of E-cadherin in cervical intraepithelial neoplasia and invasive squamous cell carcinoma. J Pathol. 1995 Jun;176(2):151–159. doi: 10.1002/path.1711760208. [DOI] [PubMed] [Google Scholar]
  24. Vijeyasingam R., Darnton S. J., Jenner K., Allen C. A., Billingham C., Matthews H. R. Expression of p53 protein in oesophageal carcinoma: clinicopathological correlation and prognostic significance. Br J Surg. 1994 Nov;81(11):1623–1626. doi: 10.1002/bjs.1800811120. [DOI] [PubMed] [Google Scholar]
  25. Wang D. Y., Xiang Y. Y., Tanaka M., Li X. R., Li J. L., Shen Q., Sugimura H., Kino I. High prevalence of p53 protein overexpression in patients with esophageal cancer in Linxian, China and its relationship to progression and prognosis. Cancer. 1994 Dec 15;74(12):3089–3096. doi: 10.1002/1097-0142(19941215)74:12<3089::aid-cncr2820741205>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES